Estimated cytomegalovirus seroprevalence in the general population of the United States and Canada
- PMID: 38529529
- DOI: 10.1002/jmv.29525
Estimated cytomegalovirus seroprevalence in the general population of the United States and Canada
Abstract
Seroprevalence data for cytomegalovirus (CMV), a widespread virus causing lifelong infection, vary widely, and contemporary data from the United States (US) and Canada are limited. Utilizing a modeling approach based on a literature review (conducted August, 2022) of data published since 2005, we determine age-, sex-, and country-specific CMV seroprevalence in the general US and Canadian populations. Sex-specific data were extracted by age categories, and a random-effects meta-regression model was used to fit the reported data (incorporating splines for the US). Seven studies reported US CMV seroprevalence (both sexes, aged 1‒89 years); all used National Health and Nutrition Examination Survey data. Due to limited population-based studies, Canadian estimates were modeled using other limited country data. In both countries, modeled seroprevalence estimates increased with age and were higher in females versus males (US: 49.0% vs. 41.6% at 18‒19 years; 61.5% vs. 50.0% at 38‒39 years; Canada: 23.7% vs. 13.7% at 18‒19 years; 32.6% vs. 22.6% at 38‒39 years). Notably, by young adulthood, one-half of US and one-quarter of Canadian females have acquired CMV. The observed differences in CMV seroprevalence in the US and Canada may partially reflect variations in general population characteristics.
Keywords: CMV; congenital cytomegalovirus; cytomegalovirus; epidemiology; seroprevalence.
© 2024 The Authors. Journal of Medical Virology published by Wiley Periodicals LLC.
References
REFERENCES
-
- Centers for Disease Control and Prevention. Cytomegalovirus (CMV) and Congenital CMV Infection ‐ Clinical Overview. Accessed October 26, 2023. https://www.cdc.gov/cmv/clinical/overview.html
-
- Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK. The “silent” global burden of congenital cytomegalovirus. Clin Microbiol Rev. 2013;26(1):86‐102. doi:10.1128/cmr.00062-12
-
- Centers for Disease Control and Prevention. About Cytomegalovirus (CMV). Updated August 18, 2020. Accessed August 18, 2023. https://www.cdc.gov/cmv/overview.html
-
- Griffiths P, Baraniak I, Reeves M. The pathogenesis of human cytomegalovirus. J Pathol. 2015;235(2):288‐297. doi:10.1002/path.4437
-
- Emery VC, Sabin CA, Cope AV, Gor D, Hassan‐Walker AF, Griffiths PD. Application of viral‐load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet. 2000;355(9220):2032‐2036. doi:10.1016/S0140-6736(00)02350-3
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
